Multimodal Spectroscopic Evaluation of Cervical Cancer.

宫颈癌的多模态光谱评估。

• 批准号: 6706335
• 负责人: Shabbir Bakir Bambot
• 金额: $ 63.41万
• 依托单位: GUIDED THERAPEUTICS
• 依托单位国家: 美国
• 财政年份: 2000
• 资助国家: 美国
• 起止时间: 2000-04-01 至 2006-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6706335
• 关键词: bioengineering /biomedical engineering; biomedical equipment development; cervix neoplasms; charge coupled device camera; clinical research; diagnosis design /evaluation; early diagnosis; fiber optics; fluorescence spectrometry; human subject; imaging /visualization /scanning; neoplasm /cancer diagnosis; noninvasive diagnosis; reflection spectrometry

DESCRIPTION (provided by applicant): Cervical Cancer is the second most common type of cancer in women worldwide and the leading cause of cancer related mortality in women in developing countries. We have developed non-invasive point-of-care devices to detect early cancerous conditions of the uterine cervix. In a Phase I funded effort we analyzed data obtained with early prototypes to determine device features most relevant to diagnostic performance. We also incorporated into the design device aspects found to be important from our experience with the clinical use of the early prototypes as well as feedback from marketing studies. Using data from 71 patient subjects enrolled for preliminary testing with the validation device we continue to show promising results. For the phase II effort we have proposed device claims that support our market positioning of the device and a comprehensive data accrual and clinical plan to validate our claims. Our phase II effort will conclude with a pivotal trial that includes the pre-production version of our validation device and an FDA PMA application.

描述（由申请人提供）： 宫颈癌是全世界女性第二常见的癌症类型，也是发展中国家女性癌症相关死亡的主要原因。 我们开发了非侵入性护理点设备来检测宫颈的早期癌变。 在第一阶段资助的工作中，我们分析了通过早期原型获得的数据，以确定与诊断性能最相关的设备功能。 我们还根据早期原型的临床使用经验以及营销研究的反馈，将我们发现的重要的设计设备方面纳入其中。 使用 71 名参加验证设备初步测试的患者受试者的数据，我们继续显示出有希望的结果。 对于第二阶段的工作，我们提出了支持我们设备市场定位的设备声明，以及全面的数据累积和临床计划来验证我们的声明。 我们的第二阶段工作将以一项关键试验结束，其中包括我们验证设备的预生产版本和 FDA PMA 申请。